» Articles » PMID: 21633846

Radiologic and Nuclear Medicine Predictors of Tumor Invasiveness in Patients with Clinical Stage IA Lung Adenocarcinoma

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2011 Jun 3
PMID 21633846
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to analyze parameters to predict tumor invasiveness according to high-resolution computed tomography and positron emission tomography in patients with clinical stage IA lung adenocarcinoma.

Methods: A total of 122 patients with clinical stage IA lung adenocarcinoma were enrolled in the study. Receiver operating characteristic (ROC) curves were constructed for three factors--the degree of solid tumor component (solid%), maximum standard uptake value (SUVmax) and tumor size--and cutoff values were determined to reveal the highest sensitivity and specificity to diagnose tumor invasiveness. We created an algorithm for detecting tumor invasiveness (model 1). The data for the three factors were combined and their ROC curves constructed (model 2). A prospective study was conducted to validate the utility of these models.

Results: Multivariate analysis identified solid%, SUVmax, and tumor size as potentially important predictors of tumor invasiveness. In the ROC curve analysis, solid% (area under the curve was 0.882) had the largest area under the curve, followed by the SUV (0.867) and tumor size (0.747). The combination assay using all three factors had the highest sensitivity and specificity for prediction (0.902). Models 1 and 2 were applied to the prospectively enrolled cases, and their utility was reviewed. Both models showed 100% sensitivity, with model 2 showing a slightly higher diagnostic value than model 1.

Conclusions: The solid portion ratio was a more powerful clinical predictor for lymphovascular invasion than the SUVmax. Our novel scoring model for tumor invasiveness can be employed for preoperative assessment of tumor invasiveness.

References
1.
Okada M, Nishio W, Sakamoto T, Uchino K, Hanioka K, Ohbayashi C . Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg. 2004; 127(3):857-61. DOI: 10.1016/j.jtcvs.2003.08.048. View

2.
Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A . Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 2005; 129(1):87-93. DOI: 10.1016/j.jtcvs.2004.04.030. View

3.
Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, Katsuda Y . The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg. 1994; 108(4):684-6. View

4.
Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S . Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995; 75(12):2844-52. DOI: 10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-#. View

5.
Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M . Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg. 2001; 122(2):325-30. DOI: 10.1067/mtc.2001.114355. View